Available but inaccessible: patient experiences during the first 2 years of a primary care-based medical cannabis program at an academic medical center
-
Published:2024-01-02
Issue:1
Volume:21
Page:
-
ISSN:1477-7517
-
Container-title:Harm Reduction Journal
-
language:en
-
Short-container-title:Harm Reduct J
Author:
Freitag Eloise W.,Zolotov Yuval,Annam Jayabhargav,Labins Jaqueline,Yamada Jaclyn M.,Jillani Syeda Masharab,Arnsten Julia H.,Slawek Deepika E.
Abstract
Abstract
Background
Medical cannabis use and public acceptance in the United States have increased over the past 25 years. However, access to medical cannabis remains limited, particularly for underserved populations. To understand how patients experience medical cannabis accessibility, we measured medical cannabis use and barriers to use after medical cannabis certification in an urban safety-net academic medical center.
Methods
We conducted a retrospective cohort study among patients seen in Montefiore’s Medical Cannabis Program (MMCP) from 2017 to 2019. Patient demographic and clinical characteristics, as well purchase history of medical cannabis, were extracted from electronic medical records. We also administered a phone questionnaire to a subset of patients to assess usage patterns, effectiveness, and barriers to medical cannabis use.
Results
Among 562 patients who were newly certified for medical cannabis between 2017 and 2019, 45% purchased medical cannabis, while 55% did not. Patients who purchased medical cannabis were more likely to be white and have private insurance or Medicare. Unregulated cannabis use and current tobacco use were less common among those who purchased medical cannabis. In multivariable logistic regression analysis, unregulated cannabis use remained negatively associated with purchasing medical cannabis. Patients reported that affordability and dispensary accessibility were their main barriers to purchasing medical cannabis.
Conclusion
Among patients certified for medical cannabis use, fewer than half purchased medical cannabis after certification. Improving access to medical cannabis is crucial for ensuring equitable access to regulated cannabis, and to reducing unregulated cannabis use.
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Medicine (miscellaneous)
Reference26 articles.
1. Green TV. Americans overwhelmingly say marijuana should be legal for medical or recreational use [Internet]. Pew Research Center. 2021 [cited 2023 Jun 5]. Available from: https://www.pewresearch.org/short-reads/2022/11/22/americans-overwhelmingly-say-marijuana-should-be-legal-for-medical-or-recreational-use/
2. Ortiz NR, Preuss CV. Controlled Substance Act. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023;24. Available from: http://www.ncbi.nlm.nih.gov/books/NBK574544/
3. Donnelly J, Young M, Marshall B, Hecht ML, Saldutti E. Public health implications of cannabis legalization: an exploration of adolescent use and evidence-based interventions. Int J Environ Res Public Health. 2022;19(6):3336.
4. National Conference of State Legislatures (NCSL). State Medical Cannabis Laws [Internet]. 2023;22. Available from: https://www.ncsl.org/health/state-medical-cannabis-laws (Accessed: 17 July 2023).
5. New York (.gov). Assessment of the Potential Impact of Regulated Marijuana in New York State. 2018;13. Available from: https://cannabis.ny.gov/system/files/documents/2019/03/executivesummary07-13-18.pdf